Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd
sales@dingminpharma.com
86-311-67260775
Αρ. μοντέλου: CAS 1421373-65-0
Μάρκα: ΫΜ
Grade Standard: Medicine Grade
Type: Chemical Reagent
State: Solid
Volatile: Not Volatile
Συσκευασία: Διπλό PE με σακούλα αλουμινίου
παραγωγικότητα: 100kg/month
μεταφορά: Ocean,Air
Τόπος καταγωγής: Hebei, Κίνα
Στήριγμα: 100kg/month
Πιστοποιητικό: ISO9001
Λιμάνι: Shanghai
Τρόπος Πληρωμής: L/C,T/T,Paypal
Incoterm: FOB,CIF
| Item Name | AZD-9291/ Osimertinib |
| CAS NO | 1421373-65-0 |
| Function |
Osimertinib (previously known as mereletinib or AZD9291) is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor drug.
Osimertinib is a Kinase Inhibitor. The mechanism of action of osimertinib is as a Kinase Inhibitor, and Cytochrome P450 3A Inhibitor, and Cytochrome P450 3A4 Inducer, and Cytochrome P450 1A2 Inducer, and Breast Cancer Resistance Protein Inhibitor.
Osimertinib used in the therapy of selected forms of advanced non-small cell lung cancer (NSCLC). Osimertinib is associated with a moderate rate of serum aminotransferase elevations during therapy and rare instances of clinically apparent acute liver injury. |
| Apparence | White Powder |
| Package | Aluminum Bag;Drums;Paper Box Outside |
| Shipment | FedEx;DHL;UPS;TNT;EMS;Sea;Air. |
| Payment | Western Union;T/T;Trade Assurance;L/C |
| Warranty | 2 Years |
Είμαστε ο επαγγελματίας κατασκευαστής API, πρώτης ύλης φαρμακοποιίας, φαρμακευτικών ενδιάμεσων, ενεργών φαρμακευτικών συστατικών, αγροχημικών ενδιάμεσων και λεπτών χημικών.
Κατηγορίες Προϊόντων : API και ενδιάμεσα > Σκόνη APIS
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Contact Now